BIO-key International, Inc.(BKYI)Earnings, Financials & Key Ratios

BKYI•NASDAQ

$5.89

Price updated Jul 7, 2026

SectorIndustrials IndustrySecurity Services Sub-IndustryElectronic Security Systems and Monitoring

AboutBIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.Show more

Revenue$6M-12.0%
EBITDA-$4M-9.9%
Net Income-$5M-6.7%
EPS (Diluted)-6.91+66.9%
Gross Margin77.47%-4.8%
EBITDA Margin-63.7%-24.9%
Operating Margin-69.89%-20.7%
Net Margin-75.31%-21.3%
ROE-80.25%+54.9%

BKYI Price & Volume

BIO-key International, Inc. (BKYI) stock price & volume — 10-year historical chart

Loading chart...

Persistent Operating Losses Undermine Revenue Growth Potential

Investment Thesis • Updated 2026Q1

VerdictNegative

Growth:Mixed

Profitability:Negative

Financial:Vulnerable

Cash Flow:Burning

Primary Risk:Liquidity and dilution risk

Key Thesis Takeaways

BIO-key International faces a challenging fundamental outlook characterized by erratic top-line performance and a persistent inability to achieve operating leverage, as evidenced by consistent net losses over the last ten quarters.
While the company maintains high gross margins exceeding 82.5% in 2026Q1, these gains are consistently offset by excessive SG&A and R&D expenditures that exceed gross profit.
Investors should remain cautious regarding the company's long-term viability, as the current cash position of $2.2M and ongoing negative free cash flow suggest a high risk of future dilutive capital raises.

Verdict Logic

the company's inability to generate positive free cash flow, coupled with a precarious cash balance of $2.2M against ongoing quarterly losses, suggests significant liquidity and dilution risks for shareholders.

BKYI Growth Metrics

BIO-key International, Inc. (BKYI) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years1.48%

5 Years16.53%

3 Years-4.6%

TTM4.37%

Profit CAGR

10 Years-

5 Years-

3 Years-

TTM14.67%

EPS CAGR

10 Years-

5 Years-

3 Years-

TTM69.42%

Return on Capital

10 Years-106.77%

5 Years-117.15%

3 Years-155.65%

Last Year-72.01%

BKYI Recent Earnings

BIO-key International, Inc. (BKYI) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 5/12 qtrs (42%)●Beat Revenue 3/12 qtrs (25%)

Q2 2026Latest

May 18, 2026

Metric

Actual

Est

EPS

$0.15+75.0%

$0.60

Rev

$2M-2.5%

$2M

Q2 2026

Mar 31, 2026

Metric

Actual

Est

EPS

$1.90-171.4%

$0.70

Rev

$1M-43.6%

$2M

Q4 2025

Nov 14, 2025

Metric

Actual

Est

EPS

$0.15-25.0%

$0.12

Rev

$2M-13.9%

$2M

Q3 2025

Aug 13, 2025

Metric

Actual

Est

EPS

$0.20-33.3%

$0.15

Rev

$2M-0.2%

$2M

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q2 2026Latest	May 18, 2026	$0.15vs $0.60+75.0%	$2Mvs $2M-2.5%
Q2 2026	Mar 31, 2026	$1.90vs $0.70-171.4%	$1Mvs $2M-43.6%
Q4 2025	Nov 14, 2025	$0.15vs $0.12-25.0%	$2Mvs $2M-13.9%
Q3 2025	Aug 13, 2025	$0.20vs $0.15-33.3%	$2Mvs $2M-0.2%

Based on last 12 quarters of dataView full earnings history →

Latest BKYI News

Recent stock market news and headlines for BIO-key International, Inc. (BKYI)

GlobeNewsWire·1 day ago

BIO-key Regains Compliance with Nasdaq Listing Rules; Nasdaq Trading Resumes on Wednesday, July 8th

HOLMDEL, N.J., July 07, 2026 (GLOBE NEWSWIRE) -- BIO-key ® International, Inc. (Nasdaq: BKYI), a global leader in Identity and Access Management and biometric authentication technologies, today announced that The Nasdaq Stock Market LLC has notified it that the trading of its common stock will recommence on the Nasdaq Capital Market effective with markets' opening on Wednesday, July 8, 2026.

GlobeNewsWire·6 days ago

BIO-key Showcases Passwordless & Biometric Identity Solutions at Jordan Banking Cybersecurity Workshop in Amman on July 6th

BIO-key (BKYI) a global leader in biometric-powered identity & access management to participate at Jordan Banking Cybersecurity Workshop in Amman, July 6.

GlobeNewsWire·Jun 18, 2026

BIO-key's Fireside Chat at Maxim Group Defense Tech Conf. to Webcast Thur.

Biometric authentication provider BIO-key's (BKYI) CEO will participate in a webcast fireside chat at Maxim Group's Defense Tech Conf. 6-25 at 4pm, track 2

Peers Comparison

Key metrics vs top competitors for BIO-key International, Inc. (BKYI)

Full Screener →

Company	Price	Market Cap	P/E Ratio	Rev Growth (1Y)	Net Margin	ROE	Div Yield
BKYIBIO-key International, Inc.Current	$5.89	$3.92M	-0.85	-12.04%	-75.31%	-80.25%	—
IDAIT Stamp Inc.	$2.14	$5M	-0.80	1.85%	-250.66%	-134.07%	—
XTLBXTL Biopharmaceuticals Ltd.	$2.98	$327.88K	-0.31	—	-227.72%	-25.53%	—
AUIDauthID Inc.	$1.21	$19.52M	-0.88	130.2%	-811.67%	-202.13%	—
VNETVNET Group, Inc.	$7.71	$2.11B	-58.20	17.18%	-21.78%	-26.68%	—
QLYSQualys, Inc.	$157.55	$5.55B	28.96	10.13%	29.41%	37.15%	—

Compare BKYI vs Peers

BIO-key International, Inc. (BKYI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs IDAI

Most directly comparable listed peer for BKYI.

Scale Benchmark

vs MSFT

Larger-name benchmark to compare BKYI against a more recognizable public peer.

Peer Set

Compare Top 5

vs IDAI, XTLB, AUID, VNET

BKYI SEC Filings & Documents

BIO-key International, Inc. (BKYI) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

Jun 10, 2026·SEC

Material company update

May 18, 2026·SEC

Material company update

May 12, 2026·SEC

10-K Annual Reports

FY 2026

Jun 12, 2026·SEC

FY 2025

Apr 23, 2025·SEC

FY 2024

Jun 5, 2024·SEC

10-Q Quarterly Reports

FY 2026

Jun 22, 2026·SEC

FY 2025

Nov 14, 2025·SEC

FY 2025

Aug 13, 2025·SEC

Get notified when BKYI posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

BKYI Frequently Asked Questions

BIO-key International, Inc. (BKYI) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

What is BIO-key International, Inc.'s revenue?

BIO-key International, Inc. (BKYI) reported $6.6M in revenue for fiscal year 2025. This represents a 20630% increase from $0.0M in 1996.

How fast is BIO-key International, Inc. growing?

BIO-key International, Inc. (BKYI) saw revenue decline by 12.0% over the past year.

Is BKYI profitable?

BIO-key International, Inc. (BKYI) reported a net loss of $4.0M for fiscal year 2025.

Dividend & Returns

What is BKYI's return on equity?

BIO-key International, Inc. (BKYI) has a return on equity (ROE) of -80.2%. Negative ROE indicates the company is unprofitable.

What is BIO-key International, Inc.'s free cash flow?

BIO-key International, Inc. (BKYI) had negative free cash flow of $4.2M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in BKYI back in 1996?

Total return calculator · dividends reinvested · 30+ years of data

See returns →

Quarter

Date

EPS (Act vs Est)

Revenue (Act vs Est)

Q2 2026Latest

May 18, 2026

$0.15vs $0.60+75.0%

$2Mvs $2M-2.5%

Q2 2026

Mar 31, 2026

$1.90vs $0.70-171.4%

$1Mvs $2M-43.6%

Q4 2025

Nov 14, 2025

$0.15vs $0.12-25.0%

$2Mvs $2M-13.9%

Q3 2025

Aug 13, 2025

$0.20vs $0.15-33.3%

$2Mvs $2M-0.2%

Company

Price

Market Cap

P/E Ratio

Rev Growth (1Y)

Net Margin

ROE

Div Yield

BKYIBIO-key International, Inc.Current

$5.89

$3.92M

-0.85

-12.04%

-75.31%

-80.25%

—

IDAIT Stamp Inc.

$2.14

$5M

-0.80

1.85%

-250.66%

-134.07%

—

XTLBXTL Biopharmaceuticals Ltd.

$2.98

$327.88K

-0.31

—

-227.72%

-25.53%

—

AUIDauthID Inc.

$1.21

$19.52M

-0.88

130.2%

-811.67%

-202.13%

—

VNETVNET Group, Inc.

$7.71

$2.11B

-58.20

17.18%

-21.78%

-26.68%

—

QLYSQualys, Inc.

$157.55

$5.55B

28.96

10.13%

29.41%

37.15%

—